38112003: 1 (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
1	Is a	General adjectival modifier	false	Inferred relationship	Some
1	Is a	Number	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely piperacillin anhydrous (as piperacillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength numerator value	False	1	Inferred relationship	Some	1
Product containing precisely piperacillin anhydrous (as piperacillin sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Bacitracin A 50000 unit powder for solution for injection vial	Count of base of active ingredient	False	1	Inferred relationship	Some
Bacitracin A 50000 unit powder for solution for injection vial	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Adrenaline 1 microgram/mg and lidocaine hydrochloride 100 microgram/mg cutaneous patch	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Adrenaline 1 microgram/mg and lidocaine hydrochloride 100 microgram/mg cutaneous patch	Has concentration strength denominator value	False	1	Inferred relationship	Some	2
Product containing precisely recombinant human antithrombin III 1750 unit/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely recombinant human antithrombin III 1750 unit/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely cefotetan (as cefotetan disodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely cefotetan (as cefotetan disodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely acetic acid 2.5 milligram/1 milliliter conventional release solution for irrigation (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely acetic acid 2.5 milligram/1 milliliter conventional release solution for irrigation (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely azithromycin anhydrous (as azithromycin monohydrate) 10 milligram/1 milliliter conventional release eye solution (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely azithromycin anhydrous (as azithromycin monohydrate) 10 milligram/1 milliliter conventional release eye solution (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Sodium chloride 9 mg/mL solution for irrigation	Count of base of active ingredient	False	1	Inferred relationship	Some
Sodium chloride 9 mg/mL solution for irrigation	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Cefazolin (as cefazolin sodium) 10 g powder for solution for injection vial	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Cefazolin (as cefazolin sodium) 10 g powder for solution for injection vial	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely azithromycin anhydrous (as azithromycin monohydrate) 20 milligram/1 milliliter conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely azithromycin anhydrous (as azithromycin monohydrate) 20 milligram/1 milliliter conventional release oral suspension (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely ceftazidime anhydrous (as ceftazidime) 40 milligram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely cefmetazole (as cefmetazole sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength numerator value	False	1	Inferred relationship	Some	1
Product containing precisely cefmetazole (as cefmetazole sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely cefmetazole (as cefmetazole sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 120 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 8.58 milligram/1 milliliter conventional release oral suspension (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	2
Product containing precisely amoxicillin anhydrous (as amoxicillin) 120 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 8.58 milligram/1 milliliter conventional release oral suspension (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Coagulation factor VIII 500 unit and von Willebrand factor 1250 unit powder for solution for injection vial	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Coagulation factor VIII 500 unit and von Willebrand factor 1250 unit powder for solution for injection vial	Has presentation strength denominator value	False	1	Inferred relationship	Some	2
Product containing precisely cytarabine 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely cytarabine 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Lidocaine 50 microgram/mg cutaneous patch	Count of base of active ingredient	False	1	Inferred relationship	Some
Lidocaine 50 microgram/mg cutaneous patch	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely doxycycline anhydrous (as doxycycline calcium) 10 milligram/1 milliliter conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely doxycycline anhydrous (as doxycycline calcium) 10 milligram/1 milliliter conventional release oral suspension (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely tesamorelin (as tesamorelin acetate) 1 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely tesamorelin (as tesamorelin acetate) 1 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely tesamorelin (as tesamorelin acetate) 1 milligram/1 vial lyophilized powder for conventional release solution for injection (clinical drug)	Has presentation strength numerator value	False	1	Inferred relationship	Some	1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 80 milligram/1 milliliter conventional release oral suspension (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 80 milligram/1 milliliter conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely ticarcillin (as ticarcillin disodium) 20 gram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely ticarcillin (as ticarcillin disodium) 20 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Mezlocillin (as mezlocillin sodium) 2 g powder for solution for injection vial	Count of base of active ingredient	False	1	Inferred relationship	Some
Mezlocillin (as mezlocillin sodium) 2 g powder for solution for injection vial	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 250 milligram/1 each conventional release chewable tablet (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 250 milligram/1 each conventional release chewable tablet (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely dyclonine hydrochloride 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely dyclonine hydrochloride 5 milligram/1 milliliter conventional release cutaneous solution (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Ceftizoxime (as ceftizoxime sodium) 500 mg powder for solution for injection vial	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Ceftizoxime (as ceftizoxime sodium) 500 mg powder for solution for injection vial	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely oxygen 0.995 milliliter/1 milliliter conventional release gas for inhalation (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely oxygen 0.995 milliliter/1 milliliter conventional release gas for inhalation (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Cefaclor anhydrous (as cefaclor) 75 mg/mL oral suspension	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Cefaclor anhydrous (as cefaclor) 75 mg/mL oral suspension	Count of base of active ingredient	False	1	Inferred relationship	Some
Mezlocillin (as mezlocillin sodium) 3 g powder for solution for injection vial	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Mezlocillin (as mezlocillin sodium) 3 g powder for solution for injection vial	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely somatrem 5 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely somatrem 5 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely clavulanic acid (as clavulanate potassium) 1 milligram and ticarcillin (as ticarcillin disodium) 30 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength numerator value	False	1	Inferred relationship	Some	2
Product containing precisely clavulanic acid (as clavulanate potassium) 1 milligram and ticarcillin (as ticarcillin disodium) 30 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	2
Product containing precisely clavulanic acid (as clavulanate potassium) 1 milligram and ticarcillin (as ticarcillin disodium) 30 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Mezlocillin (as mezlocillin sodium) 4 g powder for solution for injection vial	Count of base of active ingredient	False	1	Inferred relationship	Some
Mezlocillin (as mezlocillin sodium) 4 g powder for solution for injection vial	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 25 milligram/1 milliliter conventional release oral suspension (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 25 milligram/1 milliliter conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Plicamycin 2.5 g powder for solution for injection vial	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Plicamycin 2.5 g powder for solution for injection vial	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely ceftriaxone (as ceftriaxone sodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely ceftriaxone (as ceftriaxone sodium) 10 gram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely noxytiolin 2.5 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely noxytiolin 2.5 gram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely mandelic acid 10 milligram/1 milliliter conventional release solution for irrigation (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely mandelic acid 10 milligram/1 milliliter conventional release solution for irrigation (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely cefalexin anhydrous (as cefalexin) 25 milligram/1 milliliter conventional release oral solution (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely cefalexin anhydrous (as cefalexin) 25 milligram/1 milliliter conventional release oral solution (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Lidocaine hydrochloride 20 mg/mL oromucosal spray	Count of base of active ingredient	False	1	Inferred relationship	Some
Lidocaine hydrochloride 20 mg/mL oromucosal spray	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely vancomycin (as vancomycin hydrochloride) 10 gram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely vancomycin (as vancomycin hydrochloride) 10 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely asparaginase 10000 unit/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely asparaginase 10000 unit/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Cefalexin anhydrous (as cefalexin) 25 mg/mL oral suspension	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Cefalexin anhydrous (as cefalexin) 25 mg/mL oral suspension	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely streptokinase 250000 unit/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely streptokinase 250000 unit/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely lansoprazole 30 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely lansoprazole 30 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Cefalexin anhydrous (as cefalexin) 50 mg/mL oral solution	Count of base of active ingredient	False	1	Inferred relationship	Some
Cefalexin anhydrous (as cefalexin) 50 mg/mL oral solution	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely peginterferon alfa-2b 50 microgram/1 pen powder for conventional release solution for injection (clinical drug)	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely peginterferon alfa-2b 50 microgram/1 pen powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Cefoperazone (as cefoperazone sodium) 10 g powder for solution for injection vial	Count of base of active ingredient	False	1	Inferred relationship	Some
Cefoperazone (as cefoperazone sodium) 10 g powder for solution for injection vial	Has presentation strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely coal tar 25 milligram/1 milliliter and lecithin 3 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely coal tar 25 milligram/1 milliliter and lecithin 3 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	2
Product containing precisely coal tar 20 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Product containing precisely coal tar 20 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug)	Count of base of active ingredient	False	1	Inferred relationship	Some
Product containing precisely salicylic acid 30 milligram/1 milliliter and sulfur 50 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	2
Product containing precisely salicylic acid 30 milligram/1 milliliter and sulfur 50 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug)	Has concentration strength denominator value	False	1	Inferred relationship	Some	1
Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution	Has concentration strength denominator value	False	1	Inferred relationship	Some	1

Start Previous Page 202 of 215 Next End

Reference Sets

Concept inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
64719019	One	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442104013	1 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442105014	1	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core